IVF

Endometriosis and Fertility: What the Clinical Evidence Actually Shows

8 September 2026 · 6 min read · Kolkata

Endometriosis and Fertility: What the Evidence Actually Shows

If you have been diagnosed with endometriosis and are trying to conceive, you have probably read wildly conflicting things online — from 'you can never get pregnant naturally' to 'it barely matters.' The truth, as the research shows, sits in a more nuanced and ultimately more useful place. This article walks through what the data actually says about endometriosis, fertility outcomes, IVF success rates, and the factors that genuinely move the needle.

Why Measuring Fertility Outcomes Is More Complicated Than It Looks

Before diving into success rates, it is worth understanding how fertility outcomes are measured — because the metric you look at changes everything.

Clinical pregnancy rate (CPR) counts pregnancies confirmed by ultrasound at around six weeks. Live birth rate (LBR) counts babies actually born alive. The gap between the two can be significant: miscarriage, biochemical pregnancies, and ectopic pregnancies all count as clinical pregnancies but not live births.

When evaluating any clinic or any study on endometriosis and IVF, always ask: are they quoting CPR or LBR? Live birth rate is the only number that truly reflects the outcome patients care about.


What Endometriosis Actually Does to Fertility

Endometriosis is a condition in which tissue similar to the uterine lining grows outside the uterus — on the ovaries, fallopian tubes, the peritoneum, and sometimes beyond. It affects roughly 10% of women of reproductive age worldwide, and Indian data suggest a similar prevalence, though underdiagnosis remains a significant problem.

The condition impairs fertility through several overlapping mechanisms:

  • Distorted pelvic anatomy: adhesions and scarring can block or kink the fallopian tubes, preventing natural fertilisation.
  • Endometriomas (ovarian cysts): these 'chocolate cysts' on the ovaries can directly reduce ovarian reserve by destroying healthy follicular tissue.
  • Inflammatory environment: the peritoneal fluid in women with endometriosis contains elevated inflammatory cytokines that are hostile to eggs, sperm, and early embryos.
  • Impaired endometrial receptivity: research suggests the endometrium in affected women may not respond as efficiently to implantation signals, even when embryo quality is good.
  • Reduced ovarian reserve: repeated endometriomas or surgeries to remove them progressively deplete the ovarian pool, reflected in lower AMH levels and lower antral follicle counts (AFC).

Not every woman with endometriosis experiences all of these — stage and location of disease matter enormously.


Staging and What It Means for IVF Outcomes

Endometriosis is graded from Stage I (minimal) to Stage IV (severe) by the American Society for Reproductive Medicine (ASRM) classification. The staging system is imperfect — it was designed to describe anatomical disease extent, not fertility prognosis — but it remains the most widely used benchmark.

Stages I and II (minimal to mild) Multiple studies, including a landmark Cochrane review, show that Stage I/II endometriosis has a surprisingly small independent effect on IVF live birth rates when ovarian reserve is preserved. Some analyses find no statistically significant difference in LBR compared to women with unexplained infertility. The primary concern at these stages is the inflammatory pelvic environment rather than structural damage.

Stages III and IV (moderate to severe) This is where data shows a clearer negative impact. A meta-analysis published in Human Reproduction Update found that women with Stage III/IV endometriosis had significantly lower oocyte yield per retrieval cycle and lower clinical pregnancy rates than control groups. Live birth rates in severe endometriosis are typically reported 10–15 percentage points lower than in age-matched women undergoing IVF for tubal factor infertility — though outcomes vary widely by clinic and individual ovarian reserve.


The Ovarian Reserve Question: AMH, AFC, and Why They Matter

Anti-Müllerian hormone (AMH) is the most reliable single marker of ovarian reserve, and it is consistently lower in women with endometriosis — especially those who have had endometrioma surgery.

Here is what the evidence shows about surgery and reserve:

  • Cystectomy (surgical removal of endometriomas) improves pelvic symptoms and reduces endometrioma recurrence, but every surgery carries a risk of removing healthy ovarian cortex along with the cyst wall. Studies suggest a mean AMH reduction of 30–40% after a single endometrioma cystectomy.
  • Repeated surgeries compound this risk significantly. The ESHRE (European Society of Human Reproduction and Embryology) guidelines specifically caution against repeat cystectomy before IVF if the primary goal is to protect ovarian reserve.
  • Egg freezing before surgery is increasingly being discussed as a strategy for younger women with large endometriomas who want to preserve their future fertility options.

If your AMH is low due to endometriosis, the fertility equation shifts: fewer eggs retrieved means fewer embryos, and the importance of maximising each IVF cycle increases.


Does Surgery Before IVF Actually Improve Live Birth Rates?

This is one of the most debated questions in reproductive medicine, and the honest answer is: it depends.

For endometriomas specifically, the ESHRE guideline states there is no conclusive evidence that surgical removal of an endometrioma before IVF improves pregnancy rates in women who already have a good ovarian reserve. If the cyst is small (under 4 cm) and not causing symptoms, many specialists now recommend proceeding directly to IVF.

For deep infiltrating endometriosis (DIE) — where lesions penetrate the bowel, bladder, or ureter — surgical treatment before IVF may be warranted to restore anatomy and improve endometrial receptivity, but the evidence is still evolving.

The takeaway is that surgical decisions in endometriosis patients must be individualised, weighing anatomical burden, ovarian reserve, age, and the patient's specific fertility goals.


IVF Protocols That Matter When You Have Endometriosis

Not all IVF protocols are equal for endometriosis patients. Current evidence broadly favours:

  • GnRH agonist long protocol: pre-treatment with a GnRH agonist (downregulation) for 2–3 months before stimulation is associated with improved clinical pregnancy rates in endometriosis patients in several RCTs. The mechanism is thought to involve suppression of the inflammatory endometrial environment.
  • Progesterone-primed or frozen embryo transfer (FET) cycles: when endometrial receptivity is a concern, transferring in a controlled FET cycle rather than a fresh transfer may improve implantation.
  • ERA (Endometrial Receptivity Analysis): some centres use ERA testing to time the progesterone window precisely, though large RCT evidence for its universal benefit is still being gathered.

At Abha Surgy Centre, the approach to each patient's protocol is individualised based on their disease stage, hormone profile, and previous treatment history — because no single protocol fits all.


The One Thing Data Cannot Fully Capture: Emotional Burden

Studies consistently document higher rates of anxiety and depression among women with endometriosis undergoing fertility treatment compared to those without the diagnosis. Chronic pelvic pain, diagnostic delays (the average time to diagnosis in India is reported at 7–10 years in some surveys), and the uncertainty of IVF outcomes compound each other.

Acknowledging this is not a soft aside — it is clinically relevant. Psychological stress influences treatment adherence, and evidence shows that supported patients have better engagement with their protocols.


What You Should Do If You Have Endometriosis and Want to Conceive

The evidence points to a few clear action steps:

  1. Get a baseline AMH and AFC measured sooner rather than later — ovarian reserve can decline faster with endometriosis than it would otherwise.
  2. Ask specifically about live birth rates, not just pregnancy rates, when evaluating clinics or interpreting studies.
  3. Discuss surgical vs. non-surgical paths with a specialist who weighs both your pain symptoms and your fertility goals together.
  4. Do not delay unnecessarily — age remains the single most powerful predictor of IVF success, even when endometriosis is in the picture.

If you are in Kolkata and navigating these decisions, the team at Abha Surgy Centre offers fertility assessments that include detailed ovarian reserve evaluation and endometriosis-specific IVF counselling.

This article is for informational purposes only. Please consult a qualified fertility specialist before making any medical decisions about your care.

Follow us on

Frequently asked questions

Can I get pregnant naturally if I have endometriosis?

Yes — many women with Stage I or Stage II endometriosis do conceive naturally, though it may take longer. Stages III and IV with structural damage to tubes or ovaries make natural conception significantly harder. A fertility workup will give you a clearer personal picture based on your anatomy and ovarian reserve.

What is the IVF success rate for women with endometriosis?

It varies by stage and age. Women with Stage I/II endometriosis often have IVF live birth rates comparable to unexplained infertility patients. Stage III/IV is associated with 10–15 percentage point lower live birth rates on average, though individual outcomes depend heavily on age, AMH, and the number of mature eggs retrieved.

Should I have surgery to remove my endometrioma before starting IVF?

Current ESHRE guidelines suggest that for small endometriomas (under 4 cm) in women with good ovarian reserve, proceeding directly to IVF is reasonable. Surgery risks reducing AMH and ovarian reserve. For larger cysts or those causing symptoms, surgical and fertility goals need to be weighed together by your specialist.

Does endometriosis cause miscarriage?

Some studies suggest a modestly elevated miscarriage risk in women with endometriosis, possibly linked to impaired endometrial receptivity or the inflammatory pelvic environment. However, miscarriage rates in IVF cycles for endometriosis are not dramatically higher than in other diagnostic groups, and many women carry pregnancies to term successfully.

What does AMH being low because of endometriosis mean for my IVF chances?

Low AMH signals reduced ovarian reserve — meaning fewer eggs are likely to be retrieved per stimulation cycle. It does not mean IVF is impossible, but it does raise the stakes of each cycle. Your specialist may adjust the stimulation protocol and discuss options like mild-stimulation IVF or banking embryos over multiple cycles.

Is there an IVF protocol specifically recommended for endometriosis patients?

Evidence broadly supports a GnRH agonist long protocol with 2–3 months of downregulation before stimulation in endometriosis patients, as it may suppress the inflammatory environment and improve egg quality. Frozen embryo transfer cycles are also favoured when endometrial receptivity is a concern. Your protocol should be individualised.

How is endometriosis diagnosed, and why does it take so long?

Definitive diagnosis requires laparoscopy (a surgical procedure), which is why it is often delayed — symptoms like painful periods are frequently dismissed. In India, diagnostic delays of 7–10 years are reported. Pelvic ultrasound can identify endometriomas but misses peritoneal lesions. If you suspect endometriosis, push for a specialist referral and do not accept 'it's just bad periods' as an answer.

Author: Abha Surgy Centre Medical Team

Medically reviewed by: Dr. Bani Kumar Mitra, FRCOG

Last reviewed: 9 September 2026

Part of the Indira IVF family

Endometriosis & Fertility: Evidence on IVF Success Rates · Abha Surgy Centre, Kolkata